SBC Medical Group Holdings Incorporated (SBC) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SBC SEC filings page.
SBC Medical Group Holdings Incorporated (SBC) reported $175.2M in revenue over the twelve months to Jun 30, 2026, down 6.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
SBC's earnings became more profitable on a smaller revenue base, while its balance sheet expanded and financing became more prominent.
From FY2024 to FY2025, revenue fell15.5% while net margin widened to29.4% ; earnings therefore improved relative to sales rather than being driven by top-line growth. Meanwhile, gross margin fell to73.3% while operating margin rose to38.9% , indicating that the margin change came from operating items below gross profit, not simply cheaper production.
FY2025 net income of
The asset base reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of SBC Medical Group Holdings Incorporated's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
SBC Medical Group Holdings Incorporated has an operating margin of 38.9%, meaning the company retains $39 of operating profit per $100 of revenue. This strong profitability earns a score of 97/100, reflecting efficient cost management and pricing power. This is up from 34.2% the prior year.
SBC Medical Group Holdings Incorporated's revenue declined 15.5% year-over-year, from $205.4M to $173.6M. This contraction results in a growth score of 16/100.
SBC Medical Group Holdings Incorporated carries a low D/E ratio of 0.17, meaning only $0.17 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.78, SBC Medical Group Holdings Incorporated holds $3.78 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 86/100.
SBC Medical Group Holdings Incorporated converts 13.4% of revenue into free cash flow ($23.3M). This strong cash generation earns a score of 75/100.
SBC Medical Group Holdings Incorporated earns a strong 20.5% return on equity (ROE), meaning it generates $21 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 88/100. This is down from 23.9% the prior year.
SBC Medical Group Holdings Incorporated scores 5.28, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($549.2M) relative to total liabilities ($117.1M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
SBC Medical Group Holdings Incorporated passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, SBC Medical Group Holdings Incorporated generates $0.48 in operating cash flow ($24.7M OCF vs $51.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
SBC Medical Group Holdings Incorporated earns $455.26 in operating income for every $1 of interest expense ($67.5M vs $148K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
SBC Medical Group Holdings Incorporated generated $49.2M in revenue in Q2 2026. This represents an increase of 13.4% from the same quarter a year earlier. Against the prior quarter it is up 14.2%.
SBC Medical Group Holdings Incorporated's EBITDA was $20.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 32.3% from the same quarter a year earlier. Against the prior quarter it is up 9.3%.
SBC Medical Group Holdings Incorporated reported $10.7M in net income in Q2 2026. This represents an increase of 335.0% from the same quarter a year earlier. Against the prior quarter it is down 5.4%.
SBC Medical Group Holdings Incorporated earned $0.10 per diluted share (EPS) in Q2 2026. This represents an increase of 400.0% from the same quarter a year earlier. Against the prior quarter it is down 9.1%.
Cash & Balance Sheet
SBC Medical Group Holdings Incorporated generated $22.4M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 359.4% from the same quarter a year earlier. Against the prior quarter it is up 146.2%.
SBC Medical Group Holdings Incorporated held $184.3M in cash against $37.8M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
SBC Medical Group Holdings Incorporated's gross margin was 73.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 3.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.7 percentage points.
SBC Medical Group Holdings Incorporated's operating margin was 38.6% in Q2 2026, reflecting core business profitability. This is up 5.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.6 percentage points.
SBC Medical Group Holdings Incorporated's net profit margin was 21.7% in Q2 2026, showing the share of revenue converted to profit. This is up 16.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.5 percentage points.
SBC Medical Group Holdings Incorporated's ROE was 4.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.
Capital Allocation
SBC Medical Group Holdings Incorporated invested $84K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 72.5% from the same quarter a year earlier. Against the prior quarter it is down 32.5%.
Not reported for Q2 2026.
Not reported for Q2 2026.
SBC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $49.2M+13.4% | $43.1M-9.0% | $39.6M-10.9% | $43.4M-18.3% | $43.4M-18.3% | $47.3M-13.6% | $44.4M | $53.1M+12.3% |
| Cost of Revenue | $13.2M-1.0% | $12.7M+32.5% | $10.6M+0.9% | $12.7M+29.4% | $13.3M-2.4% | $9.6M-37.2% | $10.5M | $9.8M-28.6% |
| Gross Profit | $36.0M+19.9% | $30.3M-19.6% | $28.9M-14.6% | $30.6M-29.2% | $30.0M-23.9% | $37.7M-4.5% | $33.9M | $43.2M+29.1% |
| SG&A Expenses | $17.0M+10.1% | $12.6M-6.7% | $16.1M+15.8% | $14.7M-11.2% | $15.5M+27.4% | $13.5M-10.1% | $13.9M | $16.6M+23.4% |
| Operating Income | $19.0M+30.3% | $17.7M-26.8% | $12.8M+172.4% | $15.9M+14.8% | $14.6M-46.7% | $24.2M-1.1% | $4.7M | $13.8M-30.9% |
| EBITDA | $20.1M+32.3% | $18.4M-25.9% | $13.5M+139.4% | $16.6M+11.9% | $15.2M-46.0% | $24.8M-2.5% | $5.6M | $14.9M-36.3% |
| Interest Expense | $126K+170.2% | $112K+2724.0% | $53K+325.4% | $45K+720.5% | $47K+528.7% | $4K+31.7% | $12K | $5K+37.4% |
| Income Tax | $7.8M-29.5% | $7.5M-24.4% | $4.3M+977.5% | $5.7M-44.8% | $11.1M+30.1% | $10.0M+17.8% | -$489K | $10.3M-21.0% |
| Net Income | $10.7M+335.0% | $11.3M-47.4% | $14.2M+117.2% | $12.8M+352.7% | $2.5M-86.7% | $21.5M+14.6% | $6.5M | $2.8M-66.1% |
| EPS (Basic) | $0.10+400.0% | $0.11-47.6% | $0.14+133.3% | $0.12+300.0% | $0.02-90.0% | $0.21+5.0% | $0.06-60.0% | $0.03-66.7% |
| EPS (Diluted) | $0.10+400.0% | $0.11-47.6% | $0.14+133.3% | $0.12+300.0% | $0.02-90.0% | $0.21+5.0% | $0.06-60.0% | $0.03-66.7% |
| Diluted Shares (Avg) | 103M-0.9% | 103M-0.7% | N/A | 103M+7.9% | 104M+9.9% | 103M+9.6% | N/A | 95M+1.0% |
Not reported in any period shown, so not listed: R&D Expenses.
SBC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $406.7M+29.0% | $388.0M+36.3% | $380.4M+43.0% | $321.4M+8.4% | $315.3M+1514.8% | $284.6M+1341.0% | $266.1M+2.8% | $296.5M+1282.3% |
| Current Assets | $259.4M+7.5% | $238.8M+11.0% | $231.2M+25.4% | $227.2M+12.4% | $241.3M+16612.4% | $215.1M+12056.5% | $184.5M+11.2% | $202.1M+27065.8% |
| Cash & Equivalents | $184.3M+20.7% | $167.3M+26.7% | $163.8M+31.0% | $127.4M-7.3% | $152.7M+10929.5% | $132.1M+7856.4% | $125.0M+21.4% | $137.4M+23822.1% |
| Short-Term Investments | $308K | $314K | $319K | $0 | $0 | $0 | $0 | $0 |
| Inventory | $3.0M+74.7% | $2.3M+37.1% | $2.8M+86.8% | $1.7M-15.5% | $1.7M | $1.7M | $1.5M-51.6% | $2.0M |
| Long-Term Investments | $1.3M | $1.2M | $1.3M-57.4% | $0-100.0% | $0 | $0 | $3.0M+259.1% | $4.9M |
| Goodwill | $15.2M+202.9% | $15.4M+222.1% | $15.4M+234.5% | $4.9M+38.9% | $5.0M | $4.8M | $4.6M+28.5% | $3.5M |
| Total Liabilities | $126.7M+79.4% | $117.6M+101.8% | $117.1M+64.8% | $73.3M-19.4% | $70.6M+730.2% | $58.3M+591.7% | $71.1M-38.2% | $91.0M+236.7% |
| Current Liabilities | $78.5M+29.3% | $62.6M+29.1% | $61.1M-0.1% | $44.6M-38.4% | $60.7M+1253.1% | $48.5M+1001.3% | $61.2M-33.8% | $72.4M+2860.5% |
| Non-Current Liabilities | $48.3M+384.5% | $55.1M+460.9% | $56.0M+467.7% | $28.7M+54.9% | $10.0M+147.6% | $9.8M+143.9% | $9.9M-56.2% | $18.5M-24.6% |
| Long-Term Debt | $37.8M+431.7% | $40.4M+489.0% | $42.8M+549.0% | $21.1M+2466.1% | $7.1M | $6.9M | $6.6M | $823K |
| Total Equity | $263.8M+7.9% | $255.3M+12.8% | $248.3M+27.3% | $248.0M+21.0% | $244.6M+2669.8% | $226.4M+2411.1% | $195.1M+37.2% | $205.0M+3780.3% |
| Retained Earnings | $262.4M+23.0% | $251.8M+19.3% | $240.4M+26.9% | $226.2M+23.7% | $213.4M+3335.6% | $211.0M+3455.1% | $189.5M+32.6% | $182.9M+3384.1% |
Not reported in any period shown, so not listed: Accounts Receivable.
SBC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $22.5M+369.9% | $9.2M+378.7% | $52.0M+811.5% | -$20.9M-516.7% | -$8.3M-143.5% | $1.9M-47.6% | -$7.3M-126.2% | $5.0M-79.2% |
| Depreciation & Amortization | $1.1M+78.0% | $670K+6.7% | $674K-27.7% | $746K-26.7% | $636K-23.4% | $628K-38.3% | $932K-63.6% | $1.0M-69.0% |
| Stock-Based Compensation | N/A | N/A | N/A | $0-100.0% | N/A | N/A | N/A | $12.8M |
| Capital Expenditures | $84K-72.5% | $125K-50.7% | $798K+35.1% | $43K-89.5% | $307K-64.5% | $254K-63.9% | $590K-90.5% | $409K |
| Free Cash Flow | $22.4M+359.4% | $9.1M+443.7% | $51.2M+748.2% | -$20.9M-554.7% | -$8.6M-147.2% | $1.7M-43.8% | -$7.9M-136.4% | $4.6M |
| Investing Cash Flow | $565K-96.5% | -$528K+46.1% | -$24.2M-432.3% | -$12.2M-415.7% | $16.4M+372.4% | -$979K+71.2% | -$4.5M+33.8% | $3.9M+104.2% |
| Financing Cash Flow | -$2.0M-127.3% | -$1.8M-557.1% | $19.8M+74.2% | $11.6M-1.1% | $7.2M+10491.7% | -$280K-597.0% | $11.4M+9046.1% | $11.7M-88.9% |
| Share Buybacks | N/A | N/A | $0 | $2.6M | N/A | N/A | $0 | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
SBC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.1%+3.9pp | 70.5%-9.3pp | 73.1%-3.1pp | 70.6%-10.8pp | 69.2%-5.0pp | 79.7%+7.6pp | 76.3% | 81.5%+10.6pp |
| Operating Margin | 38.6%+5.0pp | 41.1%-10.0pp | 32.5%+21.8pp | 36.6%+10.6pp | 33.6%-17.8pp | 51.1%+6.5pp | 10.6% | 26.1%-16.3pp |
| Net Margin | 21.7%+16.1pp | 26.3%-19.2pp | 35.9%+21.2pp | 29.6%+24.2pp | 5.7%-29.1pp | 45.4%+11.2pp | 14.7% | 5.3%-12.3pp |
| Return on Equity | 4.0%+3.0pp | 4.4%-5.1pp | 5.7%+2.4pp | 5.2%+3.8pp | 1.0%-208.3pp | 9.5%-198.5pp | 3.4% | 1.4% |
| Return on Assets | 2.6%+1.9pp | 2.9%-4.7pp | 3.7%+1.3pp | 4.0%+3.0pp | 0.8%-93.9pp | 7.6%-87.4pp | 2.5% | 1.0%-38.0pp |
| Current Ratio | 3.31-0.7x | 3.82-0.6x | 3.78+0.8x | 5.10+2.3x | 3.98+3.7x | 4.44+4.0x | 3.01+1.2x | 2.79+2.5x |
| Debt-to-Equity | 0.14+0.1x | 0.16+0.1x | 0.17+0.1x | 0.09+0.1x | 0.03-0.9x | 0.03-0.9x | 0.03-0.8x | 0.00 |
| Asset Turnover | 0.120.0x | 0.11-0.1x | 0.10-0.1x | 0.130.0x | 0.14-2.6x | 0.17-2.6x | 0.17 | 0.18-2.0x |
| FCF Margin | 45.6%+65.5pp | 21.1%+17.6pp | 129.3% | -48.3%-56.9pp | -19.9%-54.5pp | 3.5%-1.9pp | -17.8% | 8.7% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| SBC Medical Group Holdings Incorporated SBC | FY2025 | $173.6M | $51.0M | 29.4% | $549.2M | 77/100 |
| CRA International, Inc. CRAI | FY2025 | $751.6M | $54.8M | 7.3% | $1.1B | 53/100 |
| Diginex Limited DGNX | FY2025 | $2.0M | -$5.2M | N/A | $37.3M | 16/100 |
| ICF International, Inc. ICFI | FY2025 | $1.9B | $92.0M | 4.9% | $1.5B | 47/100 |
| Roma Green Finance Limited ROMA | FY2026 | $1.2M | -$3.5M | N/A | $524.2M | 32/100 |
| Forrester Research Inc FORR | FY2025 | $396.9M | -$119.4M | -30.1% | $213.8M | 29/100 |
Where SBC Medical Group Holdings Incorporated Ranks
Frequently Asked Questions
What is SBC Medical Group Holdings Incorporated's annual revenue?
SBC Medical Group Holdings Incorporated (SBC) reported $173.6M in total revenue for fiscal year 2025. This represents a -15.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is SBC Medical Group Holdings Incorporated's revenue growing?
SBC Medical Group Holdings Incorporated (SBC) revenue declined by 15.5% year-over-year, from $205.4M to $173.6M in fiscal year 2025.
Is SBC Medical Group Holdings Incorporated profitable?
Yes, SBC Medical Group Holdings Incorporated (SBC) reported a net income of $51.0M in fiscal year 2025, with a net profit margin of 29.4%.
What is SBC Medical Group Holdings Incorporated's EBITDA?
SBC Medical Group Holdings Incorporated (SBC) had EBITDA of $70.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does SBC Medical Group Holdings Incorporated have?
As of fiscal year 2025, SBC Medical Group Holdings Incorporated (SBC) had $163.8M in cash and equivalents against $42.8M in long-term debt.
What is SBC Medical Group Holdings Incorporated's gross margin?
SBC Medical Group Holdings Incorporated (SBC) had a gross margin of 73.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is SBC Medical Group Holdings Incorporated's operating margin?
SBC Medical Group Holdings Incorporated (SBC) had an operating margin of 38.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is SBC Medical Group Holdings Incorporated's net profit margin?
SBC Medical Group Holdings Incorporated (SBC) had a net profit margin of 29.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is SBC Medical Group Holdings Incorporated's return on equity (ROE)?
SBC Medical Group Holdings Incorporated (SBC) has a return on equity of 20.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is SBC Medical Group Holdings Incorporated's free cash flow?
SBC Medical Group Holdings Incorporated (SBC) generated $23.3M in free cash flow during fiscal year 2025. This represents a 29.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is SBC Medical Group Holdings Incorporated's operating cash flow?
SBC Medical Group Holdings Incorporated (SBC) generated $24.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are SBC Medical Group Holdings Incorporated's total assets?
SBC Medical Group Holdings Incorporated (SBC) had $380.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are SBC Medical Group Holdings Incorporated's capital expenditures?
SBC Medical Group Holdings Incorporated (SBC) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is SBC Medical Group Holdings Incorporated's current ratio?
SBC Medical Group Holdings Incorporated (SBC) had a current ratio of 3.78 as of fiscal year 2025, which is generally considered healthy.
What is SBC Medical Group Holdings Incorporated's debt-to-equity ratio?
SBC Medical Group Holdings Incorporated (SBC) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is SBC Medical Group Holdings Incorporated's return on assets (ROA)?
SBC Medical Group Holdings Incorporated (SBC) had a return on assets of 13.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is SBC Medical Group Holdings Incorporated's P/E ratio?
SBC Medical Group Holdings Incorporated (SBC) trades at 11.2x earnings, its market capitalization divided by net income of $49.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $549.2M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is SBC Medical Group Holdings Incorporated's price-to-sales ratio?
SBC Medical Group Holdings Incorporated (SBC) trades at 3.1x sales, its market capitalization divided by revenue of $175.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $549.2M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is SBC Medical Group Holdings Incorporated's Altman Z-Score?
SBC Medical Group Holdings Incorporated (SBC) has an Altman Z-Score of 5.28, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is SBC Medical Group Holdings Incorporated's Piotroski F-Score?
SBC Medical Group Holdings Incorporated (SBC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are SBC Medical Group Holdings Incorporated's earnings high quality?
SBC Medical Group Holdings Incorporated (SBC) has an earnings quality ratio of 0.48x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can SBC Medical Group Holdings Incorporated cover its interest payments?
SBC Medical Group Holdings Incorporated (SBC) has an interest coverage ratio of 455.26x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is SBC Medical Group Holdings Incorporated?
SBC Medical Group Holdings Incorporated (SBC) scores 77 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.